By estimating the proportion of liver cancer deaths that can be averted through surveillance and other public health measures, we underscore the critical importance of early detection and proactive intervention.
The panel discussion then takes these research findings and highlights the role of research in driving effective advocacy, illustrating how robust scientific findings can catalyse plans for potentially transformative action. We hope to empower you to become an advocate for change, utilising research-backed findings to champion policies and practices that reduce the burden of liver cancer in our society.
Preventing liver cancer: Assessing the benefits of risk assessment for patients with metabolic-associated fatty liver diseaseResource category: ReportsDate
Infographic: Assessing the benefits and costs of risk-stratified surveillance for patients with metabolic-associated fatty liver diseaseResource category: VisualsDate